326
Views
10
CrossRef citations to date
0
Altmetric
Letters

Search for a concentration–effect curve of adalimumab in ankylosing spondylitis patients

, , , , , , , & show all
Pages 331-334 | Accepted 27 Oct 2015, Published online: 04 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Konstantinos Papamichael, Erik H. Vogelzang, Jo Lambert, Gertjan Wolbink & Adam S. Cheifetz. (2019) Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases. Expert Review of Clinical Immunology 15:8, pages 837-848.
Read now

Articles from other publishers (9)

Liseth de Wolff, Suzanne Arends, Elisabeth Brouwer, Hendrika Bootsma & Anneke Spoorenberg. (2023) High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis. Arthritis Research & Therapy 25:1.
Crossref
Ingrid Jyssum, Johanna E Gehin, Joseph Sexton, Eirik Klami Kristianslund, Yi Hu, David John Warren, Tore K Kvien, Espen A Haavardsholm, Silje Watterdal Syversen, Nils Bolstad & Guro Løvik Goll. (2023) Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases. Rheumatology.
Crossref
Charlotte LM Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, Borja Hernández-Breijo, Guillaume Le Mélédo, Alejandro Balsa, Peter Böhm, Sasa Cucnik, Ori Elkayam, Guro L Goll, Femke Hooijberg, Meghna Jani, Patrick DW Kiely, Neil McCarthy, Denis Mulleman, Victoria Navarro-Compán, Katherine Payne, Martin E Perry, Chamaida Plasencia-Rodriguez, Simon R Stones, Silje Watterdal Syversen, Annick de Vries, Katherine M Ward, Gertjan Wolbink & John D Isaacs. (2023) EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases 82:1, pages 65-73.
Crossref
Charlotte Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, Guillaume le Mélédo, Alejandro Balsa, Meghna Jani, Denis Mulleman, Victoria Navarro-Compan, Gertjan Wolbink, John D Isaacs & Astrid van Tubergen. (2022) Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider. RMD Open 8:2, pages e002216.
Crossref
Xiaoliang Ding, Ruifang Zhu, Jian Wu, Ling Xue, Meihua Gu & Liyan Miao. (2020) Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients. Clinical and Translational Science 13:3, pages 547-554.
Crossref
Rianne E. van Bentum & Irene E. van der Horst-Bruinsma. (2020) Axial Spondyloarthritis in the Era of Precision Medicine. Rheumatic Disease Clinics of North America 46:2, pages 367-378.
Crossref
Johanna Elin Gehin, Guro Løvik Goll, David John Warren, Silje Watterdal Syversen, Joseph Sexton, Eldri Kveine Strand, Tore Kristian Kvien, Nils Bolstad & Elisabeth Lie. (2019) Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study. Arthritis Research & Therapy 21:1.
Crossref
Jordi Gratacós, Caridad Pontes, Xavier Juanola, Jesús Sanz, Ferran Torres, Cristina Avendaño, Antoni Vallano, Gonzalo Calvo, Eugenio de Miguel & Raimon Sanmartí. (2019) Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis. Arthritis Research & Therapy 21:1.
Crossref
Frédéric Medina, Chamaida PlasenciaPhilippe Goupille, Gilles Paintaud, Alejandro BalsaDenis Mulleman. (2017) Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis. Therapeutic Drug Monitoring 39:4, pages 360-363.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.